These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 33075563)

  • 21. Liver Pyruvate Kinase Promotes NAFLD/NASH in Both Mice and Humans in a Sex-Specific Manner.
    Chella Krishnan K; Floyd RR; Sabir S; Jayasekera DW; Leon-Mimila PV; Jones AE; Cortez AA; Shravah V; Péterfy M; Stiles L; Canizales-Quinteros S; Divakaruni AS; Huertas-Vazquez A; Lusis AJ
    Cell Mol Gastroenterol Hepatol; 2021; 11(2):389-406. PubMed ID: 32942044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serpina3c deficiency induced necroptosis promotes non-alcoholic fatty liver disease through β-catenin/Foxo1/TLR4 signaling.
    Qian LL; Ji JJ; Jiang Y; Guo JQ; Wu Y; Yang Z; Ma GS; Yao YY
    FASEB J; 2022 May; 36(5):e22316. PubMed ID: 35429042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA MEG3 Restrains Hepatic Lipogenesis via the FOXO1 Signaling Pathway in HepG2 Cells.
    Meng X; Long M; Yue N; Li Q; Chen J; Zhao H; Deng W
    Cell Biochem Biophys; 2024 Jun; 82(2):1253-1259. PubMed ID: 38713402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FOXA3 induction under endoplasmic reticulum stress contributes to non-alcoholic fatty liver disease.
    Liu C; Zhou B; Meng M; Zhao W; Wang D; Yuan Y; Zheng Y; Qiu J; Li Y; Li G; Xiong X; Bian H; Zhang H; Wang H; Ma X; Hu C; Xu L; Lu Y
    J Hepatol; 2021 Jul; 75(1):150-162. PubMed ID: 33548387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic CD147 knockout modulates liver steatosis and up-regulates autophagy in high-fat-diet-induced NAFLD mice.
    Lou J; Li C; Li ZS; Zhang T; Chen ZN; Bian H
    Biochem Biophys Res Commun; 2020 Apr; 524(4):1010-1017. PubMed ID: 32063360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SIRT1 mediates the role of RNA-binding protein QKI 5 in the synthesis of triglycerides in non-alcoholic fatty liver disease mice via the PPARα/FoxO1 signaling pathway.
    Zhang W; Sun Y; Liu W; Dong J; Chen J
    Int J Mol Med; 2019 Mar; 43(3):1271-1280. PubMed ID: 30664220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chinese herb extract improves liver steatosis by promoting the expression of high molecular weight adiponectin in NAFLD rats.
    Liu X; Tong W; Zhao X; Zhang H; Tang Y; Deng X
    Mol Med Rep; 2017 Oct; 16(4):5580-5586. PubMed ID: 28849192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circ_0057558 promotes nonalcoholic fatty liver disease by regulating ROCK1/AMPK signaling through targeting miR-206.
    Chen X; Tan QQ; Tan XR; Li SJ; Zhang XX
    Cell Death Dis; 2021 Aug; 12(9):809. PubMed ID: 34446693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kindlin-2 haploinsufficiency protects against fatty liver by targeting Foxo1 in mice.
    Gao H; Zhou L; Zhong Y; Ding Z; Lin S; Hou X; Zhou X; Shao J; Yang F; Zou X; Cao H; Xiao G
    Nat Commun; 2022 Feb; 13(1):1025. PubMed ID: 35197460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-32-5p induces hepatic steatosis and hyperlipidemia by triggering de novo lipogenesis.
    Wang YD; Wu LL; Mai YN; Wang K; Tang Y; Wang QY; Li JY; Jiang LY; Liao ZZ; Hu C; Wang YY; Liu JJ; Liu JH; Xiao XH
    Metabolism; 2023 Sep; 146():155660. PubMed ID: 37451670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pancreatic-derived factor promotes lipogenesis in the mouse liver: role of the Forkhead box 1 signaling pathway.
    Li J; Chi Y; Wang C; Wu J; Yang H; Zhang D; Zhu Y; Wang N; Yang J; Guan Y
    Hepatology; 2011 Jun; 53(6):1906-16. PubMed ID: 21412813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease.
    Kim S; Hong J; Jeon R; Kim HS
    Nutr Res; 2016 Jan; 36(1):90-100. PubMed ID: 26773785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual Specificity Phosphatase 12 Regulates Hepatic Lipid Metabolism Through Inhibition of the Lipogenesis and Apoptosis Signal-Regulating Kinase 1 Pathways.
    Huang Z; Wu LM; Zhang JL; Sabri A; Wang SJ; Qin GJ; Guo CQ; Wen HT; Du BB; Zhang DH; Kong LY; Tian XY; Yao R; Li YP; Liang C; Li PC; Wang Z; Guo JY; Li L; Dong JZ; Zhang YZ
    Hepatology; 2019 Oct; 70(4):1099-1118. PubMed ID: 30820969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE
    Nasiri-Ansari N; Nikolopoulou C; Papoutsi K; Kyrou I; Mantzoros CS; Kyriakopoulos G; Chatzigeorgiou A; Kalotychou V; Randeva MS; Chatha K; Kontzoglou K; Kaltsas G; Papavassiliou AG; Randeva HS; Kassi E
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA SRA promotes hepatic steatosis through repressing the expression of adipose triglyceride lipase (ATGL).
    Chen G; Yu D; Nian X; Liu J; Koenig RJ; Xu B; Sheng L
    Sci Rep; 2016 Oct; 6():35531. PubMed ID: 27759039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Mechanism of Betaine on Hepatic Lipid Metabolism: Inhibition of Forkhead Box O1 (FoxO1) Binding to Peroxisome Proliferator-Activated Receptor Gamma (PPARγ).
    Kim DH; Lee B; Kim MJ; Park MH; An HJ; Lee EK; Chung KW; Park JW; Yu BP; Choi JS; Chung HY
    J Agric Food Chem; 2016 Sep; 64(36):6819-25. PubMed ID: 27546313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of Secretin/Secretin Receptor Axis Ameliorates NAFLD Phenotypes.
    Chen L; Wu N; Kennedy L; Francis H; Ceci L; Zhou T; Samala N; Kyritsi K; Wu C; Sybenga A; Ekser B; Dar W; Atkins C; Meadows V; Glaser S; Alpini G
    Hepatology; 2021 Oct; 74(4):1845-1863. PubMed ID: 33928675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease.
    Xu Y; Zhu Y; Hu S; Pan X; Bawa FC; Wang HH; Wang DQ; Yin L; Zhang Y
    Mol Metab; 2021 Sep; 51():101244. PubMed ID: 33930596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state.
    Su H; Li Y; Hu D; Xie L; Ke H; Zheng X; Chen W
    Free Radic Biol Med; 2018 Oct; 126():269-286. PubMed ID: 30142454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
    Zhang J; Du H; Shen M; Zhao Z; Ye X
    J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.